Inhibition of heme crystal growth by antimalarials and other compounds: Implications for drug discovery

Biochemical Pharmacology

Volumn 66, Issue 11, 2003, Pages 2201-2212

  Chong, Curtis Robert ^a   Sullivan Jr , David Joseph ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Chloroquine; Heme crystal; Hemozoin; Ketoconazole; Malaria; Plasmodium falciparum; Quinidine

Indexed keywords

AMANTADINE; AMODIAQUINE; AMPHOTERICIN; ANTIFUNGAL AGENT; ANTIMALARIAL AGENT; ATOVAQUONE; BILIRUBIN; BIOCHANIN A; CHLOROQUINE; CHLORPHENIRAMINE; CLOTRIMAZOLE; CYPROHEPTADINE; CYTOCHROME P450 INHIBITOR; DISTAMYCIN A; ECONAZOLE; ELLIPTICINE; GENISTEIN; HEME; HEMOZOIN; IBUPROFEN; KETOCONAZOLE; MEBENDAZOLE; MEPACRINE; MICONAZOLE; NITROGEN; PARACETAMOL; PROTOPORPHYRIN ZINC; QUINIDINE; QUININE; UNINDEXED DRUG;

ARTICLE; BIOASSAY; CONCENTRATION RESPONSE; CRYSTALLIZATION; DRUG PURIFICATION; GROWTH INHIBITION; IC 50; IN VITRO STUDY; INHIBITION KINETICS; PH; PRIORITY JOURNAL; SCREENING; SOLUBILITY;

EID: 0242408771     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2003.08.009     Document Type: Article

References (75)

1. Wellems T.E., Plowe C.V. Chloroquine-resistant malaria. J. Infect. Dis. 184:2001;770-776.
2. Sturchler D. How much malaria is there worldwide? Parasitol. Today. 5:1989;39-40.
3. WHO, Malaria Fact Sheet No. 94. http://www.who.int/inf-fs/en/fact094. html 1998.
4. Macreadie I., Ginsburg H., Sirawaraporn W., Tilley L. Antimalarial drug development and new targets. Parasitol. Today. 16:2000;438-444.
5. Olliaro P.L., Yuthavong Y. An overview of chemotherapeutic targets for antimalarial drug discovery. Pharmacol. Ther. 81:1999;91-110.
6. Winstanley P. Modern chemotherapeutic options for malaria. Lancet Infect. Dis. 1:2001;242-250.
7. Egan T.J., Combrinck J.M., Egan J., Hearne G.R., Marques H.M., Ntenteni S., Sewell B.T., Smith P.J., Taylor D., Van Schalkwyk D.A., Walden J.C. Fate of haem iron in the malaria parasite Plasmodium falciparum. Biochem. J. 365:2002;343-347.
8. Krugliak M., Zhang J., Ginsburg H. Intraerythrocytic Plasmodium falciparum utilizes only a fraction of the amino acids derived from the digestion of host cell cytosol for the biosynthesis of its proteins. Mol. Biochem. Parasitol. 119:2002;249-256.
9. Gluzman I.Y., Francis S.E., Oksman A., Smith C.E., Duffin K.L., Goldberg D.E. Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway. J. Clin. Invest. 93:1994;1602-1608.
10. Orjih A.U., Banyal H.S., Chelvi R., Fitch C.D. Hemin lyses malarial parasites. Science. 214:1981;667-669.
11. Pagola S., Stephens P.W., Bohle D.S., Kosar A.D., Madsen S.K. The structure of malaria pigment beta-hematin. Nature. 404:2000;307-310.
12. Bohle D.S., Kosar A.D., Madsen S.K. Propionic acid side chain hydrogen bonding in the malaria pigment beta-hematin. Biochem. Biophys. Res. Commun. 294:2002;132-135.
13. Egan T.J. Physico-chemical aspects of hemozoin (malaria pigment) structure and formation. J. Inorg. Biochem. 91:2002;19-26.
14. Bohle D.S., Helms J.B. Synthesis of β-hematin by dehydrohalogenation of hemin. Biochem. Biophys. Res. Commun. 193:1993;504-508.
15. Slater A.F., Swiggard W.J., Orton B.R., Flitter W.D., Goldberg D.E., Cerami A., Henderson G.B. An iron-carboxylate bond links the heme units of malaria pigment. Proc. Natl. Acad. Sci. U.S.A. 88:1991;325-329.
16. Sullivan D.J. Jr., Gluzman I.Y., Russell D.G., Goldberg D.E. On the molecular mechanism of chloroquine's antimalarial action. Proc. Natl. Acad. Sci. U.S.A. 93:1996;11865-11870.
17. Sullivan D. Hemozoin: a biocrystal synthesized during the degradation of hemoglobin. In: Matsumura S, Steinbüchel A, editors. Miscellaneous biopolymers, biodegradation of synthetic polymers, vol. 9. Germany, Weinheim: Wiley-VCH, Verlag GmbH & Co.; 2002. p. 129-163; In: Steinbuchel A, editor. Biopolymers.
18. Fitch C., Cai G., Chen Y., Shoemaker J. Involvement of lipids in ferriprotoporphyrin IX polymerization in malaria. Biochim. Biophys. Acta. 1454:1999;31-37.
19. Bendrat K., Berger B.J., Cerami A. Haem polymerization in malaria. Nature. 378:1995;138.
20. Goldberg D.E., Sharma V., Oksman A., Gluzman I.Y., Wellems T.E., Piwnica-Worms D. Probing the chloroquine resistance locus of Plasmodium falciparum with a novel class of multidentate metal(III) coordination complexes. J. Biol. Chem. 272:1997;6567-6572.
21. Dorn A., Stoffel R., Matile H., Bubendorf A., Ridley R.G. Malarial haemozoin/betahaematin supports haem polymerization in the absence of protein. Nature. 374:1995;269-271.
22. Dorn A., Vippagunta S.R., Matile H., Bubendorf A., Vennerstrom J.L., Ridley R.G. A comparison and analysis of several ways to promote haematin (haem) polymerisation and an assessment of its initiation in vitro. Biochem. Pharmacol. 55:1998;737-747.
23. Slater A.F., Cerami A. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature. 355:1992;167-169.
24. Slater A.F. Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum. Pharmacol. Ther. 57:1993;203-235.
25. Homewood C.A., Jewsbury J.M., Chance M.L. The pigment formed during haemoglobin digestion by malarial and schistosomal parasites. Comp. Biochem. Physiol. 43B:1972;517-523.
26. Yayon A., Cabantchik Z.I., Ginsburg H. Susceptibility of human malaria parasites to chloroquine is pH dependent. Proc. Natl. Acad. Sci. U.S.A. 82:1985;2784-2788.
27. Cohen S.N., Phifer K.O., Yeilding K.L. Complex formation between chloroquine and ferrihaemic acid in vitro, and its effect on the antimalarial action of chloroquine. Nature. 202:1964;805-806.
28. Chou A.C., Chevli R., Fitch C.D. Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites. Biochemistry. 19:1980;1543-1549.
29. Moreau S., Perly B., Chachaty C., Deleuze C. A nuclear magnetic resonance study of the interactions of antimalarial drugs with porphyrins. Biochem. Biophys. Acta. 840:1985;107-116.
30. Vippagunta S.R., Dorn A., Matile H., Bhattacharjee A.K., Karle J.M., Ellis W.Y., Ridley R.G., Vennerstrom J.L. Structural specificity of chloroquine-hematin binding related to inhibition of hematin polymerization and parasite growth. J. Med. Chem. 42:1999;4630-4639.
31. Leed A., DuBay K., Ursos L.M., Sears D., De Dios A.C., Roepe P.D. Solution structures of antimalarial drug-heme complexes. Biochemistry. 41:2002;10245-10255.
32. Sullivan D.J. Jr., Matile H., Ridley R.G., Goldberg D.E. A common mechanism for blockade of heme polymerization by antimalarial quinolines. J. Biol. Chem. 273:1998;31103-31107.
33. Buller R., Peterson M.L., Almarsson O., Leiserowitz L. Quinoline binding site on malaria pigment crystal: a rational pathway for antimalaria drug design. Cryst. Growth Des. 2:2002;553-562.
34. Egan T.J., Mavuso W.W., Ncokazi K.K. The mechanism of beta-hematin formation in acetate solution. Parallels between hemozoin formation and biomineralization processes. Biochemistry. 40:2001;204-213.
35. Egan T., Ross D., Adams P. Quinoline anti-malarial drugs inhibit spontaneous formation of beta-haematin (malaria pigment). FEBS Lett. 352:1994;54-57.
36. Sullivan D.J., Gluzman I.Y., Goldberg D.E. Plasmodium hemozoin formation mediated by histidine-rich proteins. Science. 271:1996;219-222.
37. Chen M.M., Shi L., Sullivan D.J. Haemoproteus and Schistosoma synthesize heme polymers similar to Plasmodium hemozoin and β-hematin. Mol. Biochem. Parasitol. 113:2001;1-8.
38. Egan T.J., Mavuso W.W., Ross D.C., Marques H.M. Thermodynamic factors controlling the interaction of quinoline antimalarial drugs with ferriprotoporphyrin IX. J. Inorg. Biochem. 68:1997;137-145.
39. Huy N.T., Kamei K., Yamamoto T., Kondo Y., Kanaori K., Takano R., Tajima K., Hara S. Clotrimazole binds to heme and enhances heme-dependent hemolysis: proposed antimalarial mechanism of clotrimazole. J. Biol. Chem. 277:2002;4152-4158.
40. Slater A.F.G., Cerami A. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature. 355:1992;167-169.
41. Baelmans R., Deharo E., Munoz V., Sauvain M., Ginsburg H. Experimental conditions for testing the inhibitory activity of chloroquine on the formation of β-hematin. Exp. Parasitol. 96:2000;243-248.
42. Cole K.A., Zeigler J., Evans C.A., Wright D.W. Metalloporphyrins inhibit β-hematin (hemozoin) formation. J. Inorg. Biochem. 78:2000;109-115.
43. Hawley S.R., Bray P.G., Mungthin M., Atkinson J.D., O'Neill P.M., Ward S.A. Relationship between antimalarial drug activity, accumulation, and inhibition of heme polymerization in Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 42:1998;682-686.
44. Deharo E., Garcia R.N., Oporto P., Gimenez A., Sauvain M., Jullian V., Ginsburg H. A nonradiolabelled ferriprotoporphyrin IX biomineralisation inhibition test for the high throughput screening of antimalarial compounds. Exp. Parasitol. 100:2002;252-256.
45. Basilico N., Pagani E., Monti D., Olliaro P., Taramelli D. A microtitre-based method for measuring the haem polymerization inhibitory activity (HPIA) of antimalarial drugs. J. Antimicrob. Chemother. 42:1998;55-60.
46. Kurosawa Y., Dorn A., Kitsuji-Shirane M., Shimada H., Satoh T., Matile H., Hofheinz W., Masciadri R., Kansy M., Ridley R.G. Hematin polymerization assay as a high-throughput screen for identification of new antimalarial pharmacophores. Antimicrob. Agents Chemother. 44:2000;2638-2644.
47. Dorn A., Vippagunta S.R., Matile H., Jaquet C., Vennerstrom J.L., Ridley R.G. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Biochem. Pharmacol. 55:1998;727-736.
48. Vippagunta S.R., Dorn A., Bubendorf A., Ridley R.G., Vennerstrom J.L. Deferoxamine: stimulation of hematin polymerization and antagonism of its inhibition by chloroquine. Biochem. Pharmacol. 58:1999;817-824.
49. Vennerstrom J.L., Makler M.T., Angerhofer C.K., Williams J.A. Antimalarial dyes revisited: xanthenes, azines, oxazines and thiazines. Antimicrob. Agents Chemother. 39:1995;2671-2677.
50. Webster R.V., Craig J.C., Shyamala V., Kirby G.C., Warhurst D.C. Antimalarial activity of optical isomers of quinacrine dihydrochloride against chloroquine-sensitive and resistant Plasmodium falciparum in vitro. Biochem. Pharmocol. 42:1991;S225-S227.
51. Tiffert T., Ginsburg H., Krugliak M., Elford B.C., Lew V.L. Potent antimalarial activity of clotrimazole in in vitro cultures of Plasmodium falciparum. Proc. Natl. Acad. Sci. U.S.A. 97:2000;331-336.
52. Saliba K.J., Kirk K. Clotrimazole inhibits the growth of Plasmodium falciparum in vitro. Trans. R Soc. Trop. Med. Hyg. 92:1998;666-667.
53. Pfaller M.A., Krogstad D.J. Imidazole and polyene activity against chloroquine-resistant Plasmodium falciparum. J. Infect. Dis. 144:1981;372-375.
54. Pfaller M.A., Krogstad D.J. Oxygen enhances the antimalarial activity of the imidazoles. Am. J. Trop. Med. Hyg. 32:1983;660-665.
55. McColm A.A., McHardy N. Evaluation of a range of antimicrobial agents against the parasitic protozoa, Plasmodium falciparum, Babesia rodhaini and Theileria parva in vitro. Ann. Trop. Med. Parasitol. 78:1984;345-354.
56. Kraft C., Jenett-Siems K., Siems K., Gupta M.P., Bienzle U., Eich E. Antiplasmodial activity of isoflavones from Andira inermis. J. Ethnopharmacol. 73:2000;131-135.
57. Lombardi P., Crisanti A. Antimalarial activity of synthetic analogues of distamycin. Pharmacol. Ther. 76:1997;125-133.
58. Ginsburg H., Nissani E., Krugliak M., Williamson D.H. Selective toxicity to malaria parasites by non-intercalating DNA-binding ligands. Mol. Biochem. Parasitol. 58:1993;7-15.
59. Lee S., Inselburg J. In vitro sensitivity of Plasmodium falciparum to drugs that bind DNA or inhibit its synthesis. J. Parasitol. 79:1993;780-782.
60. Martiney J.A., Cerami A., Slater A.F. Inhibition of hemozoin formation in Plasmodium falciparum trophozoite extracts by heme analogs: possible implication in the resistance to malaria conferred by the beta-thalassemia trait. Mol. Med. 2:1996;236-246.
61. Parapini S., Basilico N., Pasini E., Egan T.J., Olliaro P., Taramelli D., Monti D. Standardization of the physicochemical parameters to assess in vitro the beta-hematin inhibitory activity of antimalarial drugs. Exp. Parasitol. 96:2000;249-256.
62. Guttmann P., Ehrlich P. Uber die wirkung des methylenblau bei malaria. Berliner Klinische Wochenschrift. 39:1891;953-956.
63. Saliba K.J., Folb P.I., Smith P.J. Role for the Plasmodium falciparum digestive vacuole in chloroquine resistance. Biochem. Pharmacol. 56:1998;313-320.
64. Egan J.T., Hunter R., Kaschula H.C., Marques M.H., Misplon A., Walden J. Structure-function relationships in aminoquinolines: effect of amino and chloro groups on quinoline-hematin complex formation, inhibition of B-hematin formation, and antiplasmodial activity. J. Med. Chem. 43:2000;283-291.
65. Fitch C.D., Kanjananggulpan P. The state of ferriprotoporphyrin IX in malaria pigment. J. Biol. Chem. 262:1987;15552-15555.
66. Adams P.A., Egan T.J., Ross D.C., Silver J., Marsh P.J. The chemical mechanism of beta haematin formation studied by Mossbauer spectroscopy. Biochem. J. 318(Pt 1):1996;25-27.
67. Ursos L.M., DuBay K.F., Roepe P.D. Antimalarial drugs influence the pH dependent solubility of heme via apparent nucleation phenomena. Mol. Biochem. Parasitol. 112:2001;11-17.
68. Lynn A., Chandra S., Malhotra P., Chauhan S.V. Heme binding and polymerization by Plasmodium falciparum histidine rich protein II: influence of pH on activity and conformation. FEBS. 459:1999;267-271.
69. Blauer G., Akkawi M. Investigations of B- and β-hematin. J. Inorg. Chem. 66:1997;145-152.
70. Otton S.V., Kalow W., Seeman P. High affinity of quinidine for a stereoselective microsomal binding site as determined by a radioreceptor assay. Experientia. 40:1984;973-974.
71. Gardner M.J., Hall N., Fung E., White O., Berriman M., Hyman R.W., Carlton J.M., Pain A., Nelson K.E., Bowman S., Paulsen I.T., James K., Eisen J.A., Rutherford K., Salzberg S.L., Craig A., Kyes S., Chan M.S., Nene V., Shallom S.J., Suh B., Peterson J., Angiuoli S., Pertea M., Allen J., Selengut J., Haft D., Mather M.W., Vaidya A.B., Martin D.M., Fairlamb A.H., Fraunholz M.J., Roos D.S., Ralph S.A., McFadden G.I., Cummings L.M., Subramanian G.M., Mungall C., Venter J.C., Carucci D.J., Hoffman S.L., Newbold C., Davis R.W., Fraser C.M., Barrell B. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature. 419:2002;498-511.
72. Surolia N., Karthikeyan G., Padmanaban G. Involvement of cytochrome P-450 in conferring chloroquine resistance to the malarial parasite, Plasmodium falciparum. Biochem. Biophys. Res. Commun. 197:1993;562-569.
73. Ndifor A.M., Ward S.A., Howells R.E. Cytochrome P-450 activity in malarial parasites and its possible relationship to chloroquine resistance. Mol. Biochem. Parasitol. 41:1990;251-257.
74. Sullivan D.J. Theories on malarial pigment formation and quinoline action. Int. J. Parasitol. 32:2002;1645-1653.
75. Podust L.M., Poulos T.L., Waterman M.R. Crystal structure of cytochrome P450 14alpha - sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc. Natl. Acad. Sci. U.S.A. 98:2001;3068-3073.